A sample size planning approach that considers both statistical significance and clinical significance.
Background: The CONSORT statement requires clinical trials to report confidence intervals, which help to assess the precision and clinical importance of the treatment effect. Conventional sample size calculations for clinical trials, however, only consider issues of statistical significance (that is...
| Published in: | Trials Vol. 16; no. 1; pp. 213 - 214 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Published: |
BioMed Central
2015
|
| Online Access: | View this record in EBSCOhost |